SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (830)10/8/1997 6:36:00 PM
From: DR. BOND   of 23519
 
TA..I agree with you!! VVUS and MUSE have reached record sales/launch levels for new drugs. I believe David said MUSE is now among the TOP 25 of all new drugs launched in terms of initial revenues. With regard to the "fireworks", .31 is GREAT! As you stated TA, capacity is constrained therefore is is near impossible to increase earnings any more than VVUS has until the new plant comes online. Remember this co. has a 71% gross profit margin, so you can't squeeeeeeeze another penny from margins. SGA were inline and the tax rate was as low as you can get!! Give me a break!!!

So SI posters are impossible to please!!!

Staying Long (and loving it)

DB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext